Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

B MadanM OZELOP RahejaE SymingtonE et alJohnny Mahlangu2024-09-292024-09-29WOS1538-7933https://hdl.handle.net/10539/41194Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia AJournal Article